AB
Aman Bhalla
About Aman Bhalla
Data last updated:
Aman Bhalla is a Director at Unipact Pharmaceuticals Private Limited (since 2020) and Additional Director at Maa Pitambara Outsourcing Private Limited (since 2022). The companies operate in Chemicals and Professional Services. The largest current company by reported revenue is Unipact Pharmaceuticals Private Limited at ₹1.21 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Aug 2020 | 2020 | ₹1.21 Cr (FY 2025) | Active | |
| Additional Director | 14 Nov 2022 | 2021 | Active |
Board colleagues of Aman Bhalla
| Name | DIN | Company | Designation |
|---|---|---|---|
| Umesh Kumar Saxena | 08826057 | Unipact Pharmaceuticals Private Limited | Director |
| Dipti Sharma | 09784501 | Maa Pitambara Outsourcing Private Limited | Additional Director |
| Jitendra Dulani | 09647050 | Maa Pitambara Outsourcing Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Aman Bhalla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aman Bhalla
Aman Bhalla currently holds 2 directorships: Unipact Pharmaceuticals Private Limited (Director, since 07 Aug 2020, revenue ₹1.21 Cr (FY 2025)); Maa Pitambara Outsourcing Private Limited (Additional Director, since 14 Nov 2022).
Aman Bhalla was first appointed on 07 Aug 2020 as Director at Unipact Pharmaceuticals Private Limited. The most recent appointment on record is 14 Nov 2022 at Maa Pitambara Outsourcing Private Limited.
The current boards of Aman Bhalla's companies include Umesh Kumar Saxena (Unipact Pharmaceuticals Private Limited), Dipti Sharma (Maa Pitambara Outsourcing Private Limited), Jitendra Dulani (Maa Pitambara Outsourcing Private Limited).